{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:06:59Z","timestamp":1795021619876,"version":"4.10.1"},"reference-count":4,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.1001\/jamaophthalmol.2020.5296","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T14:14:42Z","timestamp":1607004882000},"page":"244","source":"Crossref","is-referenced-by-count":35,"title":["Teprotumumab for Optic Neuropathy in Thyroid Eye Disease"],"prefix":"10.1001","volume":"139","author":[{"given":"Dane H.","family":"Slentz","sequence":"first","affiliation":[{"name":"W.K. Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor"},{"name":"now with the Medical Eye Center, Manchester, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry J.","family":"Smith","sequence":"additional","affiliation":[{"name":"W.K. Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor"},{"name":"Division of Metabolism and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise S.","family":"Kim","sequence":"additional","affiliation":[{"name":"W.K. Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon S.","family":"Joseph","sequence":"additional","affiliation":[{"name":"W.K. Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"18","key":"elo200014r1","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy.","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"elo200014r2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease.","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"key":"elo200014r3","doi-asserted-by":"crossref","DOI":"10.1097\/IOP.0000000000001831","article-title":"Teprotumumab for dysthyroid optic neuropathy: early response to therapy.","author":"Sears","year":"2020","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"13","key":"elo200014r4","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1001\/jama.1983.03330370053031","article-title":"If nothing goes wrong, is everything all right? interpreting zero numerators.","volume":"249","author":"Hanley","year":"1983","journal-title":"JAMA"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2773504\/jamaophthalmology_slentz_2020_lo_200014_1613153443.11074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T14:04:19Z","timestamp":1613570659000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2773504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":4,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.5296","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}